NCI trial reported targeted agent trastuzumab and standard chemo cut risk of HER-2-positive breast cancer
On Apr. 25, 2005, the combination of the targeted agent trastuzumab (Herceptin) and standard chemotherapy cuts the risk…
Moores Cancer Center at UC San Diego opened new consolidated facility
On Apr. 8, 2005, Moores Cancer Center (MCC) at University of California, San Diego opened its new consolidated…
UCLA launched $20 million stem cell institute to investigate new approaches to HIV, cancer and neurological disorders
On Mar. 16, 2005, University of California, Los Angeles (UCLA) officials announced the formation of the Institute for…
Biotechnology | Diagnostics | Disease | FDA | Life Science News | Nanotechnology | Oncology | Therapeutics
FDA approved albumin-stabilized nanoparticle formulation of paclitaxel for treatment of breast cancer
In Jan. 2005, the U.S. Food and Drug Administration (FDA) approved an albumin-stabilized nanoparticle formulation of paclitaxel (Abraxane)…
The Georgia Legislature passed the Smoke Free Air Act
In 2005, the Georgia Legislature passed the Smoke Free Air Act, banning indoor smoking in publicly accessible buildings,…
The National Cancer Institute study determined that a new molecular test can predict the risk of breast cancer recurrence
On Dec. 10, 2004, a National Cancer Institute (NCI) supported study determined that a new molecular test done…
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
Genentech drug Tarceva (erlotinib) was approved
On Nov. 18, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Genentech’s drug Tarceva…
Letrozole was approved by the FDA for the adjuvant treatment of early-stage breast cancer after five years of tamoxifen therapy
On Oct. 29, 2004, the U.S. Food and Drug Administration (FDA) approved Letrozole for the extended adjuvant treatment…
Biotechnology | Diagnostics | Disease | Environmental | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics
The National Center for Vermiculite and Asbestos-Related Cancers was established
Apr. 14, 2004, the National Center for Vermiculite and Asbestos-Related Cancers was established in Michigan in response to…
Biotechnology | Diagnostics | FDA | Life Science News | NIH | Oncology
The FDA and NCI announced they will share knowledge and resources to facilitate development of new cancer drugs
On Mar. 16, 2004, the Food and Drug Administration (FDA) released a report addressing the recent slowdown in…
FDA approved the first antiangiogenic drug for cancer, Avastin
On Feb. 26, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved the first antiangiogenic…
The monoclonal antibody cetuximab (Erbitux) was approved by the FDA for the treatment of metastatic colorectal cancer
On Feb. 1, 2004, the U.S. Food and Drug Administration (FDA) announced it had approved Cetuximab, a recombinant…
Biotechnology | Disease | FDA | Life Science News | Oncology | Therapeutics
The FDA approved oxaliplatin (Eloxatin) for use in the treatment of advanced colorectal cancer
On Jan. 9, 2004, the Food and Drug Administration (FDA) announced the approval of Sanofi’s Eloxatin (oxaliplatin) injection…
Biotechnology | Diagnostics | FDA | Life Science News | NIH | Oncology | Therapeutics
The National Cancer Institute collaborated with the Department of Health and Human Services to establish National Network of Tobacco Cessation Quitlines
In 2004, the National Cancer Institute (NCI) collaborated with the Department of Health and Human Services to establish…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Radiology | Therapeutics | Women's Health
Women’s Health Initiative data showed women who take estrogen with hormone progestin have greater risk of developing breast cancer
In 2004, data from the Women’s Health Initiative (WHI) study show that women who take estrogen in combination…
Siteman Cancer Center was designated a Comprehensive Cancer Center by the NCI
On Jan. 20, 2005, the Siteman Cancer Center received National Cancer Institute (NCI) designation as a Comprehensive Cancer…
Biotechnology | Diagnostics | Disease | Life Science News | Medical Device | Neurology | Oncology | Therapeutics
OMRF opened the state’s first small animal magnetic resonance imaging facility
In 2004, the Oklahoma Medical Research Foundation (OMRF) opened the state’s first small animal magnetic resonance imaging facility….
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Radiology | Therapeutics | Women's Health
World’s first use of low-dose radioactive palladium ‘seeds’ was used to treat breast cancer patients at the Women’s Research Institute in Toronto.
In 2004, the world’s first use of low-dose radioactive palladium ‘seeds’ as used to treat breast cancer patients…
The Huntsman Cancer Center Hospital opened
On Jun. 21, 2004, the Huntsman Cancer Center Hospital was dedicated featuring a full-field digital mammography unit, a…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Therapeutics | Women's Health
A novel approach to treatment of solid cancers involved therapeutic agents that inhibit the generation of new blood vessels in growing tumors
On Nov. 19, 2003, a novel approach to treatment of solid cancers involved therapeutic agents that inhibit the…
Biotechnology | Diagnostics | Disease | Life Science News | Oncology | Therapeutics | Women's Health
A clinical trial found post-menopausal survivors of early-stage breast cancer who took letrozole reduced risk of cancer recurrence
On Oct. 9, 2003, a Canadian-led international clinical trial found that post-menopausal survivors of early-stage breast cancer who…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics | Women's Health
Death rates from the lung, breast, prostate, and colorectal cancers continued to decline in the late 1990s
On Sept. 3, 2003, the death rates from the four most common cancers, – lung, breast, prostate, and…
Biotechnology | Disease | Life Science News | Non-Profit Research | Oncology | Pharmaceutical | Therapeutics
Results of the Prostate Cancer Prevention Trial were announced
On Jun. 24, 2003, results of the Prostate Cancer Prevention Trial (PCPT), testing the effectiveness of finasteride to…
Biotechnology | Diagnostics | Life Science News | NIH | Non-Profit Research | Oncology | Therapeutics
Data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial was announced
On Jun. 5, 2003, data from the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial gave fresh insight…
USC sold the operations of the Kenneth Norris Jr Cancer Hospital to Tenet Healthcare
On May 30, 2003, the Attorney General of California consented to the sale of the assets of the…
Amgen relocated its cancer research division to Seattle
On May 22, 2003, Amgen announced it was relocating its cancer research division to Seattle following its acquisition…
Taking daily aspirin for as little as 3 years was shown to reduce the development of colorectal polyps
On Mar. 5, 2003, taking daily aspirin for as little as 3 years was shown to reduce the…
Institute for Research in Immunology and Cancer created at the University of Montreal to discover more effective cancer therapies
In 2003, the Institute for Research in Immunology and Cancer (IRIC) was created at the University of Montreal…
Biotechnology | Diagnostics | Disease | Life Science News | NIH | Oncology | Radiology | Therapeutics
NCI clinical trial showed reduced intervals between chemotherapy improved survival in women whose breast cancer had spread to lymph nodes
On Dec. 12, 2002, the National Cancer Institute (NCI) announced that a clinical trial had shown that reducing…
Sidney Kimmel gave $150 million to Hopkins for cancer research and patient
On Dec. 1, 202, Sidney Kimmel, founder and chairman of Jones Apparel Group, donated $150 million for cancer…